Wright Investors Service’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.32M Sell
2,521
-253
-9% -$256K 0.73% 35
2025
Q4
$2.98M Buy
2,774
+1,301
+88% +$1.24M 0.9% 29
2025
Q3
$1.12M Sell
1,473
-1,102
-43% -$820K 0.33% 72
2025
Q2
$2.01M Sell
2,575
-108
-4% -$83.9K 0.61% 43
2025
Q1
$2.22M Buy
2,683
+222
+9% +$185K 0.73% 38
2024
Q4
$1.9M Sell
2,461
-1,228
-33% -$1.02M 0.62% 45
2024
Q3
$3.27M Hold
3,689
0.86% 32
2024
Q2
$3.34M Buy
3,689
+813
+28% +$650K 0.88% 32
2024
Q1
$2.24M Sell
2,876
-6
-0.2% -$4.27K 0.57% 61
2023
Q4
$1.68M Buy
+2,882
New +$1.68M 0.47% 66
2013
Q4
Sell
-5,339
Closed -$269K 228
2013
Q3
$269K Buy
5,339
+6
+0.1% +$314 0.12% 193
2013
Q2
$262K Buy
+5,333
New +$290K 0.12% 189

Other funds holding LLY

Wright Investors Service's LLY Position: Q1 2026 in Review

Wright Investors Service reduced its Eli Lilly (LLY) stake by 9.1% in Q1 2026, selling an estimated $256K and leaving 2,521 shares worth $2.32M. The position accounts for 0.73% of the portfolio, ranked #35.

Wright Investors Service first reported a position in LLY in Q2 2013 and has held it in 12 quarters since. The position peaked at $3.34M in Q2 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Wright Investors Service held 2,521 shares of Eli Lilly worth $2.32M as of Q1 2026.
  • Wright Investors Service sold 253 Eli Lilly shares in Q1 2026, an estimated $256K.
  • Eli Lilly made up 0.73% of Wright Investors Service's portfolio in Q1 2026, its #35 holding.
  • Wright Investors Service first reported a position in Eli Lilly in Q2 2013 and has held it in 12 quarters since.
  • Wright Investors Service's Eli Lilly position peaked at $3.34M in Q2 2024.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Wright Investors Service's 13F filing for Q1 2026, filed 29 Apr 2026.